DongKook Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was KRW 15,322.82 million compared to KRW 15,104.76 million a year ago. Net income was KRW 50,345.22 million compared to KRW 55,925.03 million a year ago.

Basic earnings per share from continuing operations was KRW 1,146 compared to KRW 1,273 a year ago. Diluted earnings per share from continuing operations was KRW 1,126 compared to KRW 1,251 a year ago. Basic earnings per share was KRW 1,146 compared to KRW 1,273 a year ago.

Diluted earnings per share was KRW 1,126 compared to KRW 1,251 a year ago.